Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF/MEK inhibitors in cancer patients: a meta-analysis. The gene discussed is BRAF; the disease is cutaneous squamous cell carcinoma.